Alexander Mentzer
Impact in
- Infectious Diseases top 0.02%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- SARS-CoV-2 detection and testing
- Modeling and Simulation top 0.2%
- COVID-19 epidemiological studies
Papers in
-
- SARS-CoV-2 and COVID-19 Research 61
- COVID-19 Clinical Research Studies 36
- SARS-CoV-2 detection and testing 11
- Immunology 29
- Immune Cell Function and Interaction 8
- T-cell and B-cell Immunology 8
- Co-authors
- Julian Charles Knight (12 shared papers)Manjinder S. Sandhu (4 shared papers)Deepti Gurdasani (4 shared papers)Martin Pollard (2 shared papers)Andrew Kwok (2 shared papers)Tarryn Porter (1 shared paper)Gil McVean (4 shared papers)Alexander Dilthey (3 shared papers)
- Journals
- Nature Communications (15 papers)Cell (12 papers)The Lancet (11 papers)Nature Medicine (7 papers)Nature (7 papers)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
Alexander Mentzer
184 papers receiving 21.4k citations
Alexander Mentzer's Hit Papers
Peers
Comparison fields: 5 of 199
- Infectious Diseases 13.7k
- Modeling and Simulation 1.2k
- Health 1.9k
- Neurology 1.8k
- Immunology 2.6k
Countries citing papers authored by Alexander Mentzer
This map shows the geographic impact of Alexander Mentzer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander Mentzer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander Mentzer more than expected).
Fields of papers citing papers by Alexander Mentzer
This network shows the impact of papers produced by Alexander Mentzer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander Mentzer. The network helps show where Alexander Mentzer may publish in the future.
Co-authors
The 25 scholars most cited alongside Alexander Mentzer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 191 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK Hit paper breakdown → | 2020 | 3621 |
| 2 | Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial Hit paper breakdown → | 2020 | 1899 |
| 3 | Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19 Hit paper breakdown → | 2020 | 974 |
| 4 | Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials Hit paper breakdown → | 2021 | 867 |
| 5 | Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera Hit paper breakdown → | 2021 | 755 |
| 6 | SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses Hit paper breakdown → | 2022 | 740 |
| 7 | Mapping the human genetic architecture of COVID-19 Hit paper breakdown → | 2021 | 641 |
| 8 | Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum Hit paper breakdown → | 2021 | 558 |
| 9 | Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum Hit paper breakdown → | 2022 | 547 |
| 10 | 2020 | 469 | |
| 11 | Antibody evasion by the P.1 strain of SARS-CoV-2 Hit paper breakdown → | 2021 | 452 |
| 12 | A genomic history of Aboriginal Australia Hit paper breakdown → | 2016 | 421 |
| 13 | Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 403 |
| 14 | Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial Hit paper breakdown → | 2021 | 381 |
| 15 | Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera Hit paper breakdown → | 2021 | 353 |
| 16 | Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2022 | 282 |
| 17 | 2020 | 281 | |
| 18 | The antigenic anatomy of SARS-CoV-2 receptor binding domain Hit paper breakdown → | 2021 | 279 |
| 19 | 2020 | 251 | |
| 20 | Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine Hit paper breakdown → | 2021 | 249 |
About Alexander Mentzer
Alexander Mentzer is a scholar working on Infectious Diseases, Immunology, Epidemiology, Neurology and Genetics, having authored 191 papers that have together received 22.0k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (61 papers), COVID-19 Clinical Research Studies (36 papers), vaccines and immunoinformatics approaches (12 papers), SARS-CoV-2 detection and testing (11 papers), Long-Term Effects of COVID-19 (11 papers), Immune Cell Function and Interaction (8 papers), T-cell and B-cell Immunology (8 papers) and Animal Virus Infections Studies (7 papers). The work is most often cited by research in Infectious Diseases (13.7k citations), Modeling and Simulation (1.2k citations), Health (1.9k citations), Neurology (1.8k citations) and Immunology (2.6k citations). Alexander Mentzer has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Julian Charles Knight, Manjinder S. Sandhu, Deepti Gurdasani, Martin Pollard, Andrew Kwok, Tarryn Porter, Gil McVean, Alexander Dilthey, Nezih Cereb and Jeremy David Sanderson. Their work appears in journals such as Nature Communications, Cell, The Lancet, Nature Medicine and Nature.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.